APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Biologics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Biologics Market Analysis and Forecast 2026-2032

2 January 2026201 pages

Choose your research edition.

Industry ResearchVeterinary Biologics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Biologics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Veterinary Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Biologics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Biologics Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Veterinary Biologics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Veterinary Biologics include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Biologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Biologics, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Biologics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Biologics sales, projected growth trends, production technology, application and end-user industry.

Veterinary Biologics Segment by Company

Avimex Animal

Bio-Labs

Boehringer Ingelheim

CAHIC

CAVAC

Ceva

DHN

Elanco/Eli Lilly

FATRO

HVRI

Kyoto Biken

Ringpu Biology

Vaksindo

Virbac

WINSUN

Yebio

Zoetis

ChengDu Tecbond

Jinyu Bio-Technology

Merck

Veterinary Biologics Segment by Type

Vaccines

Monoclonal Antibodies

Veterinary Biologics Segment by Application

Llivestock

Equine

Other

Veterinary Biologics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Biologics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vaccines Major Manufacturers Table 3. Monoclonal Antibodies Major Manufacturers Table 4. Global Veterinary Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Llivestock Major Manufacturers Table 6. Equine Major Manufacturers Table 7. Other Major Manufacturers Table 8. Veterinary Biologics Industry Trends Table 9. Veterinary Biologics Industry Drivers Table 10. Veterinary Biologics Industry Opportunities and Challenges Table 11. Veterinary Biologics Industry Restraints Table 12. Global Veterinary Biologics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Veterinary Biologics Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Veterinary Biologics Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Veterinary Biologics Revenue Market Share by Region (2021-2026) Table 16. Global Veterinary Biologics Revenue Market Share by Region (2027-2032) Table 17. Global Veterinary Biologics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 18. Global Veterinary Biologics Sales by Region (2021-2026) & (M Units) Table 19. Global Veterinary Biologics Sales by Region (2027-2032) & (M Units) Table 20. Global Veterinary Biologics Sales Market Share by Region (2021-2026) Table 21. Global Veterinary Biologics Sales Market Share by Region (2027-2032) Table 22. Global Veterinary Biologics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Veterinary Biologics Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Veterinary Biologics Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Veterinary Biologics Sales Market Share by Manufacturers (2021-2026) Table 26. Global Veterinary Biologics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Veterinary Biologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Veterinary Biologics Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Veterinary Biologics Manufacturers, Product Type & Application Table 30. Global Veterinary Biologics Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Veterinary Biologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Veterinary Biologics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Veterinary Biologics Revenue Market Share by Type (2021-2026) Table 37. Global Veterinary Biologics Revenue Market Share by Type (2027-2032) Table 38. Global Veterinary Biologics Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 39. Global Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 40. Global Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 41. Global Veterinary Biologics Sales Market Share by Type (2021-2026) Table 42. Global Veterinary Biologics Sales Market Share by Type (2027-2032) Table 43. Global Veterinary Biologics Price by Type (2021-2026) & (US$/Unit) Table 44. Global Veterinary Biologics Price by Type (2027-2032) & (US$/Unit) Table 45. Global Veterinary Biologics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Veterinary Biologics Revenue Market Share by Application (2021-2026) Table 49. Global Veterinary Biologics Revenue Market Share by Application (2027-2032) Table 50. Global Veterinary Biologics Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 51. Global Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 52. Global Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 53. Global Veterinary Biologics Sales Market Share by Application (2021-2026) Table 54. Global Veterinary Biologics Sales Market Share by Application (2027-2032) Table 55. Global Veterinary Biologics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Veterinary Biologics Price by Application (2027-2032) & (US$/Unit) Table 57. Avimex Animal Company Information Table 58. Avimex Animal Business Overview Table 59. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Avimex Animal Veterinary Biologics Product Portfolio Table 61. Avimex Animal Recent Development Table 62. Bio-Labs Company Information Table 63. Bio-Labs Business Overview Table 64. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Bio-Labs Veterinary Biologics Product Portfolio Table 66. Bio-Labs Recent Development Table 67. Boehringer Ingelheim Company Information Table 68. Boehringer Ingelheim Business Overview Table 69. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Boehringer Ingelheim Veterinary Biologics Product Portfolio Table 71. Boehringer Ingelheim Recent Development Table 72. CAHIC Company Information Table 73. CAHIC Business Overview Table 74. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CAHIC Veterinary Biologics Product Portfolio Table 76. CAHIC Recent Development Table 77. CAVAC Company Information Table 78. CAVAC Business Overview Table 79. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CAVAC Veterinary Biologics Product Portfolio Table 81. CAVAC Recent Development Table 82. Ceva Company Information Table 83. Ceva Business Overview Table 84. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ceva Veterinary Biologics Product Portfolio Table 86. Ceva Recent Development Table 87. DHN Company Information Table 88. DHN Business Overview Table 89. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. DHN Veterinary Biologics Product Portfolio Table 91. DHN Recent Development Table 92. Elanco/Eli Lilly Company Information Table 93. Elanco/Eli Lilly Business Overview Table 94. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Elanco/Eli Lilly Veterinary Biologics Product Portfolio Table 96. Elanco/Eli Lilly Recent Development Table 97. FATRO Company Information Table 98. FATRO Business Overview Table 99. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. FATRO Veterinary Biologics Product Portfolio Table 101. FATRO Recent Development Table 102. HVRI Company Information Table 103. HVRI Business Overview Table 104. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. HVRI Veterinary Biologics Product Portfolio Table 106. HVRI Recent Development Table 107. Kyoto Biken Company Information Table 108. Kyoto Biken Business Overview Table 109. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Kyoto Biken Veterinary Biologics Product Portfolio Table 111. Kyoto Biken Recent Development Table 112. Ringpu Biology Company Information Table 113. Ringpu Biology Business Overview Table 114. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Ringpu Biology Veterinary Biologics Product Portfolio Table 116. Ringpu Biology Recent Development Table 117. Vaksindo Company Information Table 118. Vaksindo Business Overview Table 119. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Vaksindo Veterinary Biologics Product Portfolio Table 121. Vaksindo Recent Development Table 122. Virbac Company Information Table 123. Virbac Business Overview Table 124. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Virbac Veterinary Biologics Product Portfolio Table 126. Virbac Recent Development Table 127. WINSUN Company Information Table 128. WINSUN Business Overview Table 129. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. WINSUN Veterinary Biologics Product Portfolio Table 131. WINSUN Recent Development Table 132. Yebio Company Information Table 133. Yebio Business Overview Table 134. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Yebio Veterinary Biologics Product Portfolio Table 136. Yebio Recent Development Table 137. Zoetis Company Information Table 138. Zoetis Business Overview Table 139. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Zoetis Veterinary Biologics Product Portfolio Table 141. Zoetis Recent Development Table 142. ChengDu Tecbond Company Information Table 143. ChengDu Tecbond Business Overview Table 144. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. ChengDu Tecbond Veterinary Biologics Product Portfolio Table 146. ChengDu Tecbond Recent Development Table 147. Jinyu Bio-Technology Company Information Table 148. Jinyu Bio-Technology Business Overview Table 149. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Jinyu Bio-Technology Veterinary Biologics Product Portfolio Table 151. Jinyu Bio-Technology Recent Development Table 152. Merck Company Information Table 153. Merck Business Overview Table 154. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Merck Veterinary Biologics Product Portfolio Table 156. Merck Recent Development Table 157. North America Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 160. North America Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 161. North America Veterinary Biologics Sales Price by Type (2021-2026) & (US$/Unit) Table 162. North America Veterinary Biologics Sales Price by Type (2027-2032) & (US$/Unit) Table 163. North America Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 166. North America Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 167. North America Veterinary Biologics Sales Price by Application (2021-2026) & (US$/Unit) Table 168. North America Veterinary Biologics Sales Price by Application (2027-2032) & (US$/Unit) Table 169. North America Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Veterinary Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Veterinary Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 173. North America Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 174. North America Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 175. North America Veterinary Biologics Sales Price by Country (2021-2026) & (US$/Unit) Table 176. North America Veterinary Biologics Sales Price by Country (2027-2032) & (US$/Unit) Table 177. United States Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 178. Canada Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 179. Europe Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 180. Europe Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 181. Europe Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 182. Europe Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 183. Europe Veterinary Biologics Sales Price by Type (2021-2026) & (US$/Unit) Table 184. Europe Veterinary Biologics Sales Price by Type (2027-2032) & (US$/Unit) Table 185. Europe Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 186. Europe Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 187. Europe Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 188. Europe Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 189. Europe Veterinary Biologics Sales Price by Application (2021-2026) & (US$/Unit) Table 190. Europe Veterinary Biologics Sales Price by Application (2027-2032) & (US$/Unit) Table 191. Europe Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Europe Veterinary Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Europe Veterinary Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Europe Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 195. Europe Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 196. Europe Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 197. Europe Veterinary Biologics Sales Price by Country (2021-2026) & (US$/Unit) Table 198. Europe Veterinary Biologics Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Germany Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 200. France Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 201. U.K. Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 202. Italy Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 203. Netherlands Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 204. China Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 205. China Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 206. China Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 207. China Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 208. China Veterinary Biologics Sales Price by Type (2021-2026) & (US$/Unit) Table 209. China Veterinary Biologics Sales Price by Type (2027-2032) & (US$/Unit) Table 210. China Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 211. China Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 212. China Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 213. China Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 214. China Veterinary Biologics Sales Price by Application (2021-2026) & (US$/Unit) Table 215. China Veterinary Biologics Sales Price by Application (2027-2032) & (US$/Unit) Table 216. Asia Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 219. Asia Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 220. Asia Veterinary Biologics Sales Price by Type (2021-2026) & (US$/Unit) Table 221. Asia Veterinary Biologics Sales Price by Type (2027-2032) & (US$/Unit) Table 222. Asia Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 225. Asia Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 226. Asia Veterinary Biologics Sales Price by Application (2021-2026) & (US$/Unit) Table 227. Asia Veterinary Biologics Sales Price by Application (2027-2032) & (US$/Unit) Table 228. Asia Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Veterinary Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Veterinary Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 232. Asia Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 233. Asia Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 234. Asia Veterinary Biologics Sales Price by Country (2021-2026) & (US$/Unit) Table 235. Asia Veterinary Biologics Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Japan Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 237. South Korea Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 238. India Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 239. Australia Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 240. China Taiwan Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Veterinary Biologics Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Veterinary Biologics Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 245. SAMEA Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 246. SAMEA Veterinary Biologics Sales Price by Type (2021-2026) & (US$/Unit) Table 247. SAMEA Veterinary Biologics Sales Price by Type (2027-2032) & (US$/Unit) Table 248. SAMEA Veterinary Biologics Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Veterinary Biologics Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 251. SAMEA Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 252. SAMEA Veterinary Biologics Sales Price by Application (2021-2026) & (US$/Unit) Table 253. SAMEA Veterinary Biologics Sales Price by Application (2027-2032) & (US$/Unit) Table 254. SAMEA Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Veterinary Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Veterinary Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 258. SAMEA Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 259. SAMEA Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 260. SAMEA Veterinary Biologics Sales Price by Country (2021-2026) & (US$/Unit) Table 261. SAMEA Veterinary Biologics Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Brazil Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 263. Argentina Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 264. Chile Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 265. Colombia Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 266. Peru Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 268. Israel Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 269. UAE Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 270. Turkey Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 271. Iran Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 272. Egypt Veterinary Biologics Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Veterinary Biologics Distributors List Table 276. Veterinary Biologics Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Veterinary Biologics Image Figure 2. Global Veterinary Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vaccines Image Figure 5. Monoclonal Antibodies Image Figure 6. Global Veterinary Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Veterinary Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Llivestock Image Figure 9. Equine Image Figure 10. Other Image Figure 11. Global Veterinary Biologics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Biologics Revenue (2021-2032) & (US$ Million) Figure 13. Global Veterinary Biologics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Veterinary Biologics Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Veterinary Biologics Revenue Market Share by Region (2021-2032) Figure 16. Global Veterinary Biologics Sales (2021-2032) & (M Units) Figure 17. Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 18. Global Veterinary Biologics Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Veterinary Biologics Sales YoY (2021-2032) & (M Units) Figure 20. Europe Veterinary Biologics Sales YoY (2021-2032) & (M Units) Figure 21. China Veterinary Biologics Sales YoY (2021-2032) & (M Units) Figure 22. Asia (Excluding China) Veterinary Biologics Sales YoY (2021-2032) & (M Units) Figure 23. South America, Middle East and Africa Veterinary Biologics Sales YoY (2021-2032) & (M Units) Figure 24. Global Veterinary Biologics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Veterinary Biologics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Veterinary Biologics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Veterinary Biologics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Veterinary Biologics Revenue Market Share by Type (2021-2032) Figure 30. Global Veterinary Biologics Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 31. Global Veterinary Biologics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Veterinary Biologics Sales Market Share by Type (2021-2032) Figure 33. Global Veterinary Biologics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Veterinary Biologics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Veterinary Biologics Revenue Market Share by Application (2021-2032) Figure 36. Global Veterinary Biologics Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Veterinary Biologics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Veterinary Biologics Sales Market Share by Application (2021-2032) Figure 39. North America Veterinary Biologics Revenue Share by Type (2021-2032) Figure 40. North America Veterinary Biologics Sales Share by Type (2021-2032) Figure 41. North America Veterinary Biologics Revenue Share by Application (2021-2032) Figure 42. North America Veterinary Biologics Sales Share by Application (2021-2032) Figure 43. North America Veterinary Biologics Revenue Share by Country (2021-2032) Figure 44. North America Veterinary Biologics Sales Share by Country (2021-2032) Figure 45. Europe Veterinary Biologics Revenue Share by Type (2021-2032) Figure 46. Europe Veterinary Biologics Sales Share by Type (2021-2032) Figure 47. Europe Veterinary Biologics Revenue Share by Application (2021-2032) Figure 48. Europe Veterinary Biologics Sales Share by Application (2021-2032) Figure 49. Europe Veterinary Biologics Revenue Share by Country (2021-2032) Figure 50. Europe Veterinary Biologics Sales Share by Country (2021-2032) Figure 51. China Veterinary Biologics Revenue Share by Type (2021-2032) Figure 52. China Veterinary Biologics Sales Share by Type (2021-2032) Figure 53. China Veterinary Biologics Revenue Share by Application (2021-2032) Figure 54. China Veterinary Biologics Sales Share by Application (2021-2032) Figure 55. Asia Veterinary Biologics Revenue Share by Type (2021-2032) Figure 56. Asia Veterinary Biologics Sales Share by Type (2021-2032) Figure 57. Asia Veterinary Biologics Revenue Share by Application (2021-2032) Figure 58. Asia Veterinary Biologics Sales Share by Application (2021-2032) Figure 59. Asia Veterinary Biologics Revenue Share by Country (2021-2032) Figure 60. Asia Veterinary Biologics Sales Share by Country (2021-2032) Figure 61. SAMEA Veterinary Biologics Revenue Share by Type (2021-2032) Figure 62. SAMEA Veterinary Biologics Sales Share by Type (2021-2032) Figure 63. SAMEA Veterinary Biologics Revenue Share by Application (2021-2032) Figure 64. SAMEA Veterinary Biologics Sales Share by Application (2021-2032) Figure 65. SAMEA Veterinary Biologics Revenue Share by Country (2021-2032) Figure 66. SAMEA Veterinary Biologics Sales Share by Country (2021-2032) Figure 67. Veterinary Biologics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Veterinary Biologics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Monoclonal Antibodies
Applications
  • Llivestock
  • Equine
  • Other
Companies covered
  • Avimex Animal
  • Bio-Labs
  • Boehringer Ingelheim
  • CAHIC
  • CAVAC
  • Ceva
  • DHN
  • Elanco/Eli Lilly
  • FATRO
  • HVRI
  • Kyoto Biken
  • Ringpu Biology
  • Vaksindo
  • Virbac
  • WINSUN
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Jinyu Bio-Technology
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Biologics Market by Type
  3. 1.2.1 Global Veterinary Biologics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccines
  5. 1.2.3 Monoclonal Antibodies
  6. 1.3 Veterinary Biologics Market by Application
  7. 1.3.1 Global Veterinary Biologics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Llivestock
  9. 1.3.3 Equine
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Veterinary Biologics Market Dynamics
  1. 2.1 Veterinary Biologics Industry Trends
  2. 2.2 Veterinary Biologics Industry Drivers
  3. 2.3 Veterinary Biologics Industry Opportunities and Challenges
  4. 2.4 Veterinary Biologics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Biologics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Biologics Revenue by Region
  3. 3.2.1 Global Veterinary Biologics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Biologics Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Biologics Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Biologics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Biologics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Biologics Sales by Region
  9. 3.4.1 Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Biologics Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Biologics Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Biologics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Biologics Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Biologics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Biologics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Biologics Sales by Manufacturers
  6. 4.2.1 Global Veterinary Biologics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Biologics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Biologics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Biologics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Biologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Biologics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Biologics Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Biologics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Biologics Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Biologics Tier 1, Tier 2, and Tier 3
5 Veterinary Biologics Market by Type
  1. 5.1 Global Veterinary Biologics Revenue by Type
  2. 5.1.1 Global Veterinary Biologics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Biologics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Biologics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Biologics Sales by Type
  6. 5.2.1 Global Veterinary Biologics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Biologics Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Veterinary Biologics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Biologics Price by Type
6 Veterinary Biologics Market by Application
  1. 6.1 Global Veterinary Biologics Revenue by Application
  2. 6.1.1 Global Veterinary Biologics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Biologics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Biologics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Biologics Sales by Application
  6. 6.2.1 Global Veterinary Biologics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Biologics Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Veterinary Biologics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Biologics Price by Application
7 Company Profiles
  1. 7.1 Avimex Animal
  2. 7.1.1 Avimex Animal Company Information
  3. 7.1.2 Avimex Animal Business Overview
  4. 7.1.3 Avimex Animal Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Avimex Animal Veterinary Biologics Product Portfolio
  6. 7.1.5 Avimex Animal Recent Developments
  7. 7.2 Bio-Labs
  8. 7.2.1 Bio-Labs Company Information
  9. 7.2.2 Bio-Labs Business Overview
  10. 7.2.3 Bio-Labs Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bio-Labs Veterinary Biologics Product Portfolio
  12. 7.2.5 Bio-Labs Recent Developments
  13. 7.3 Boehringer Ingelheim
  14. 7.3.1 Boehringer Ingelheim Company Information
  15. 7.3.2 Boehringer Ingelheim Business Overview
  16. 7.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
  18. 7.3.5 Boehringer Ingelheim Recent Developments
  19. 7.4 CAHIC
  20. 7.4.1 CAHIC Company Information
  21. 7.4.2 CAHIC Business Overview
  22. 7.4.3 CAHIC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CAHIC Veterinary Biologics Product Portfolio
  24. 7.4.5 CAHIC Recent Developments
  25. 7.5 CAVAC
  26. 7.5.1 CAVAC Company Information
  27. 7.5.2 CAVAC Business Overview
  28. 7.5.3 CAVAC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CAVAC Veterinary Biologics Product Portfolio
  30. 7.5.5 CAVAC Recent Developments
  31. 7.6 Ceva
  32. 7.6.1 Ceva Company Information
  33. 7.6.2 Ceva Business Overview
  34. 7.6.3 Ceva Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ceva Veterinary Biologics Product Portfolio
  36. 7.6.5 Ceva Recent Developments
  37. 7.7 DHN
  38. 7.7.1 DHN Company Information
  39. 7.7.2 DHN Business Overview
  40. 7.7.3 DHN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 DHN Veterinary Biologics Product Portfolio
  42. 7.7.5 DHN Recent Developments
  43. 7.8 Elanco/Eli Lilly
  44. 7.8.1 Elanco/Eli Lilly Company Information
  45. 7.8.2 Elanco/Eli Lilly Business Overview
  46. 7.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
  48. 7.8.5 Elanco/Eli Lilly Recent Developments
  49. 7.9 FATRO
  50. 7.9.1 FATRO Company Information
  51. 7.9.2 FATRO Business Overview
  52. 7.9.3 FATRO Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 FATRO Veterinary Biologics Product Portfolio
  54. 7.9.5 FATRO Recent Developments
  55. 7.10 HVRI
  56. 7.10.1 HVRI Company Information
  57. 7.10.2 HVRI Business Overview
  58. 7.10.3 HVRI Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 HVRI Veterinary Biologics Product Portfolio
  60. 7.10.5 HVRI Recent Developments
  61. 7.11 Kyoto Biken
  62. 7.11.1 Kyoto Biken Company Information
  63. 7.11.2 Kyoto Biken Business Overview
  64. 7.11.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
  66. 7.11.5 Kyoto Biken Recent Developments
  67. 7.12 Ringpu Biology
  68. 7.12.1 Ringpu Biology Company Information
  69. 7.12.2 Ringpu Biology Business Overview
  70. 7.12.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
  72. 7.12.5 Ringpu Biology Recent Developments
  73. 7.13 Vaksindo
  74. 7.13.1 Vaksindo Company Information
  75. 7.13.2 Vaksindo Business Overview
  76. 7.13.3 Vaksindo Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Vaksindo Veterinary Biologics Product Portfolio
  78. 7.13.5 Vaksindo Recent Developments
  79. 7.14 Virbac
  80. 7.14.1 Virbac Company Information
  81. 7.14.2 Virbac Business Overview
  82. 7.14.3 Virbac Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Virbac Veterinary Biologics Product Portfolio
  84. 7.14.5 Virbac Recent Developments
  85. 7.15 WINSUN
  86. 7.15.1 WINSUN Company Information
  87. 7.15.2 WINSUN Business Overview
  88. 7.15.3 WINSUN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 WINSUN Veterinary Biologics Product Portfolio
  90. 7.15.5 WINSUN Recent Developments
  91. 7.16 Yebio
  92. 7.16.1 Yebio Company Information
  93. 7.16.2 Yebio Business Overview
  94. 7.16.3 Yebio Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Yebio Veterinary Biologics Product Portfolio
  96. 7.16.5 Yebio Recent Developments
  97. 7.17 Zoetis
  98. 7.17.1 Zoetis Company Information
  99. 7.17.2 Zoetis Business Overview
  100. 7.17.3 Zoetis Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zoetis Veterinary Biologics Product Portfolio
  102. 7.17.5 Zoetis Recent Developments
  103. 7.18 ChengDu Tecbond
  104. 7.18.1 ChengDu Tecbond Company Information
  105. 7.18.2 ChengDu Tecbond Business Overview
  106. 7.18.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
  108. 7.18.5 ChengDu Tecbond Recent Developments
  109. 7.19 Jinyu Bio-Technology
  110. 7.19.1 Jinyu Bio-Technology Company Information
  111. 7.19.2 Jinyu Bio-Technology Business Overview
  112. 7.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
  114. 7.19.5 Jinyu Bio-Technology Recent Developments
  115. 7.20 Merck
  116. 7.20.1 Merck Company Information
  117. 7.20.2 Merck Business Overview
  118. 7.20.3 Merck Veterinary Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Merck Veterinary Biologics Product Portfolio
  120. 7.20.5 Merck Recent Developments
8 North America
  1. 8.1 North America Veterinary Biologics Market Size by Type
  2. 8.1.1 North America Veterinary Biologics Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Biologics Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Biologics Price by Type (2021-2032)
  5. 8.2 North America Veterinary Biologics Market Size by Application
  6. 8.2.1 North America Veterinary Biologics Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Biologics Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Biologics Price by Application (2021-2032)
  9. 8.3 North America Veterinary Biologics Market Size by Country
  10. 8.3.1 North America Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Biologics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Veterinary Biologics Market Size by Type
  2. 9.1.1 Europe Veterinary Biologics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Biologics Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Biologics Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Biologics Market Size by Application
  6. 9.2.1 Europe Veterinary Biologics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Biologics Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Biologics Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Biologics Market Size by Country
  10. 9.3.1 Europe Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Biologics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Veterinary Biologics Market Size by Type
  2. 10.1.1 China Veterinary Biologics Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Biologics Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Biologics Price by Type (2021-2032)
  5. 10.2 China Veterinary Biologics Market Size by Application
  6. 10.2.1 China Veterinary Biologics Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Biologics Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Biologics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Biologics Market Size by Type
  2. 11.1.1 Asia Veterinary Biologics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Biologics Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Biologics Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Biologics Market Size by Application
  6. 11.2.1 Asia Veterinary Biologics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Biologics Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Biologics Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Biologics Market Size by Country
  10. 11.3.1 Asia Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Biologics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Biologics Market Size by Type
  2. 12.1.1 SAMEA Veterinary Biologics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Biologics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Biologics Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Biologics Market Size by Application
  6. 12.2.1 SAMEA Veterinary Biologics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Biologics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Biologics Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Biologics Market Size by Country
  10. 12.3.1 SAMEA Veterinary Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Biologics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Biologics Value Chain Analysis
  2. 13.1.1 Veterinary Biologics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Biologics Production Mode & Process
  6. 13.2 Veterinary Biologics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Biologics Distributors
  9. 13.2.3 Veterinary Biologics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst